Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lignocain vs Dexmedetomidine for Hemodynamic Stress Response to Intubation
NCT07385040Phase 3Completed
- Sponsor
- Shaheed Mohtarma Benazir Bhutto Institute of Trauma
- Start
- Apr 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in tachycardia, hypertension (HTN), sponsored by Shaheed Mohtarma Benazir Bhutto Institute of Trauma. Started Apr 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
tachycardiahypertension (HTN)
Beyond the preview
Go deeper on NCT07385040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07385040.